Dolkar Tsering, Jitidhar Fnu, Patel Meet J, Hamad Abubaker M, Salauddin Ferdous, Shiferaw-Deribe Zewge, Dogar Muhammad H
Internal Medicine, One Brooklyn Health (OBH) Interfaith Medical Center, Brooklyn, USA.
Medicine, Memorial Hospital of Converse County, Douglas, USA.
Cureus. 2022 Jul 16;14(7):e26924. doi: 10.7759/cureus.26924. eCollection 2022 Jul.
Coronavirus 2019 disease (COVID-19) is a highly contagious infectious disease caused by severe acute respiratory coronavirus 2 (SARS-CoV-2). Although several articles have described the non-respiratory effects of COVID-19 in the past two years, there are few reports of COVID-19 associated with thyroiditis. We present a case of a middle-aged female patient with positive COVID-19 PCR associated with acute pulmonary embolism and thyroiditis. Three months ago, her baseline thyroid profile was normal. Thyroiditis induced elevated free thyroxine (FT4) and decreased thyroid-stimulating hormone (TSH) levels resolved with conservative management within six days.
2019冠状病毒病(COVID-19)是由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的一种高度传染性传染病。尽管在过去两年中有几篇文章描述了COVID-19的非呼吸道影响,但与甲状腺炎相关的COVID-19报道很少。我们报告一例中年女性患者,其COVID-19聚合酶链反应(PCR)检测呈阳性,同时伴有急性肺栓塞和甲状腺炎。三个月前,她的甲状腺功能基线正常。甲状腺炎导致游离甲状腺素(FT4)升高和促甲状腺激素(TSH)水平降低,经保守治疗在六天内恢复正常。